Patents by Inventor Paul Devine

Paul Devine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7429674
    Abstract: This invention relates to a stereoselective preparation of fluoroleucine alkyl esters.
    Type: Grant
    Filed: April 14, 2005
    Date of Patent: September 30, 2008
    Assignee: Merck & Co. Inc..
    Inventors: Paul Devine, John Limanto, Ali Shafiee, Veena Upadhyay
  • Publication number: 20070238878
    Abstract: The present invention is directed to processes for the preparation of 4-(sulfonylphenyl)-piperidines of the Formula (VI), and pharmaceutically acceptable salts thereof; which comprises oxidizing a sulfide of the Formula (VII) or Formula (VIII), to give a compound of the Formula (IX) or Formula (X) respectively, followed by catalic reduction of the compound of the Formula (IX) or dehydration of compound of formula (X) to give a compound of Formula (IX) followed by catalytic reduction of the compound formula (IX) to give the compound of the Formula (VI).
    Type: Application
    Filed: April 13, 2007
    Publication date: October 11, 2007
    Inventors: Richard Desmond, Paul Devine, Clas Sonesson, Donald Gauthier
  • Publication number: 20070238879
    Abstract: The present invention is directed to processes for the preparation of 4-(3-methanesulfonyl-phenyl)-1-N-propylpiperidine (I) or a pharmaceutically acceptable salt thereof, which comprises: oxidizing a sulfide of the formula (II): with a catalytic oxidizing agent and an oxidant; to give a compound of the formula (III): followed by catalytic reduction of the compound of formula (III).
    Type: Application
    Filed: April 10, 2007
    Publication date: October 11, 2007
    Inventors: Donald Gauthier, Richard Desmond, Paul Devine
  • Publication number: 20060182129
    Abstract: An apparatus for performing XML processing distributed across one or more network entities and a terminal comprised of a mobile device entity. A memory stores a transformed representation of XML information. The network entity and terminal communications are mediated by a proxy tasked with offloading XML processing other operations from the network entities or terminals participating in communications exchanges and/or XML manipulations. Advantages of the invention include the ability for network operators to optimize communications techniques based on XML Documents, XML Fragments, communication protocol components, and other forms of XML interchange and exchange.
    Type: Application
    Filed: May 11, 2005
    Publication date: August 17, 2006
    Inventors: Karl Mutch, Paul Devine
  • Publication number: 20060030731
    Abstract: This invention describes a reductive amination process whereby perfluorinated ketones or ketals are combined with ?-aminoesters under basic conditions to form metal carboxylates. Diastereoselective reductions of the metal carboxylates enable access to two diastereomers, depending on the reducing conditions.
    Type: Application
    Filed: July 29, 2005
    Publication date: February 9, 2006
    Inventors: Cheng Chen, Paul Devine, Bruce Foster, Greg Hughes, Paul O'Shea
  • Publication number: 20050234128
    Abstract: This invention relates to a stereoselective preparation of fluoroleucine alkyl esters.
    Type: Application
    Filed: April 14, 2005
    Publication date: October 20, 2005
    Inventors: Paul Devine, John Limanto, Ali Shafiee, Veena Upadhyay
  • Patent number: 6777580
    Abstract: The present invention is concerned with novel processes for the preparation of (R)-1-(3,5-bis(trifluoromethyl)phenyl)ethan-1-ol. This compound is useful as an intermediate in the synthesis of compounds which possess pharmacological activity.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: August 17, 2004
    Assignee: Merck & Co., Inc.
    Inventors: Paul Devine, Hansen Karl
  • Publication number: 20030153760
    Abstract: The present invention is concerned with novel processes for the preparation of (R)-1-(3,5-bis(trifluoromethyl)phenyl)ethan-1-ol. This compound is useful as an intermediate in the synthesis of compounds which possess pharmacological activity.
    Type: Application
    Filed: December 20, 2002
    Publication date: August 14, 2003
    Applicant: Merck & Co., Inc.
    Inventors: Paul Devine, Hansen Karl
  • Patent number: 6531617
    Abstract: Enantiomerically enriched hydroxychromanones are obtained by the AlCl3-catalyzed intramolecular Friedel-Crafts acylation of the corresponding 3-phenoxy-2-alkylcarbonyloxy-propionic acid followed by cleavage of the carboxylate in the presence of an alkali metal peroxide or hydroperoxide. Enantiomerically enriched cis-aminochromanols can then be prepared by treating the hydroxychromanones with a hydroxylamine and hydrogenating the resulting oxime. The cis-aminochromanols can be employed as intermediates in the production of HIV protease inhibitors which are useful for treating HIV infection and AIDS.
    Type: Grant
    Filed: October 24, 2001
    Date of Patent: March 11, 2003
    Assignee: Merck & Co., Inc.
    Inventors: Karl Hansen, Paul Devine, Philippe M. Rabbat
  • Patent number: 6504066
    Abstract: The present invention is concerned with novel processes for the preparation of (R)-1-(3,5-bis(trifluoromethyl)phenyl)ethan-1-ol. This compound is useful as an intermediate in the synthesis of compounds which possess pharmacological activity.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: January 7, 2003
    Assignee: Merck & Co. Inc.
    Inventors: Paul Devine, Hansen Karl
  • Publication number: 20020095047
    Abstract: Enantiomerically enriched hydroxychromanones are obtained by the AlCl3-catalyzed intramolecular Friedel-Crafts acylation of the corresponding 3-phenoxy-2-alkylcarbonyloxy-propionic acid followed by cleavage of the carboxylate in the presence of an alkali metal peroxide or hydroperoxide. Enantiomerically enriched cis-aminochromanols can then be prepared by treating the hydroxychromanones with a hydroxylamine and hydrogenating the resulting oxime. The cis-aminochromanols can be employed as intermediates in the production of HIV protease inhibitors which are useful for treating HIV infection and AIDS.
    Type: Application
    Filed: October 24, 2001
    Publication date: July 18, 2002
    Inventors: Karl Hansen, Paul Devine, Philippe M. Rabbat